Skip to main content
Equibles

NATIONAL BANK OF CANADA /FI/

Bank

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 926171 MONTREAL, A8
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$902
-$113 QoQ
Shares Held
921
-9.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 47 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIONAL BANK OF CANADA /FI/ holds $632,429,861 across 151 Biotechnology names. ATNM ranks #93 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 1,096,025 $205,263,562
2 MRNA
Moderna, Inc.
 1,424,802 $99,778,883
3 ROIV
Roivant Sciences Ltd.
 2,773,874 $98,167,400
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 172,898 $85,883,622
5 REGN
Regeneron Pharmaceuticals, Inc.
 125,812 $78,448,813
6 ALNY
Alnylam Pharmaceuticals, Inc.
 52,467 $15,794,140
7 GPCR
Structure Therapeutics Inc.
 215,800 $11,581,986
8 ABCL
AbCellera Biologics Inc.
 1,233,014 $9,679,159

All Filings in ATNM

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $902 921
2026-03-31 $1,015 1,021
2025-12-31 $1,162 855
2025-09-30 $1,368 855
2025-06-30 $1,197 855
2025-03-31 $1,376 855
2024-12-31 $1,077 855
2024-09-30 $1,607 855
2024-06-30 $6,327 855
2024-03-31 $6,694 855
2023-12-31 $4,343 855
2023-09-30 $5,061 855
2023-06-30 $6,344 855
2023-03-31 $8,079 855
2022-12-31 $9,105 855
2022-09-30 $6,309 855
2022-06-30 $4,112 855
2022-03-31 $4,369 855
2021-12-31 $5,138 855